Revolution Medicines reports sale of 2,753 shares

Revolution Medicines reported the sale of 2,753 shares of Common Stock by a selling party on 03/17/2026, with proceeds shown as $273,869.54.

Rhea-AI Filing Summary

Revolution Medicines reported the sale of 2,753 shares of Common Stock by a selling party on 03/17/2026, with proceeds shown as $273,869.54.

The filing also lists prior restricted stock unit grants of 318, 846, 840, and 649 shares dated 09/01/2022, 03/01/2023, 03/01/2024, and 03/01/2025, respectively.

Insights

Insider Transactions Specialist

Routine Form 144 sale filed showing a single reported disposition.

The submission records a sale of 2,753 shares on 03/17/2026 for $273,869.54. The filing is an orderly disclosure of an intended sale under securities rules rather than a narrative about company operations.

Context includes multiple prior restricted stock unit grants (318; 846; 840; 649) across 2022-2025, which are listed as the source of shares. Timing and method details beyond the single reported disposition are not provided in the excerpt.

Key Figures

Shares sold: 2,753 shares Proceeds: $273,869.54 RSU grant: 318 shares +3 more

6 metrics

Shares sold 2,753 shares Sale dated 03/17/2026

Proceeds $273,869.54 Proceeds reported for the 03/17/2026 sale

RSU grant 318 shares Restricted stock unit grant dated 09/01/2022

RSU grant 846 shares Restricted stock unit grant dated 03/01/2023

RSU grant 840 shares Restricted stock unit grant dated 03/01/2024

RSU grant 649 shares Restricted stock unit grant dated 03/01/2025

Key Terms

Restricted stock unit grant, Form 144, Common Stock

3 terms

Restricted stock unit grant financial

"Restricted stock unit grant | Issuer | 318 | 09/01/2022"

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Common Stock financial

"Common Stock | ETRADE Financial Corporation 3 Edison Drive Alpharetta GA 30005"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Revolution Medicines (RVMD) report in this Form 144?

The filing reports a sale of 2,753 shares on 03/17/2026 with proceeds of $273,869.54. It also lists prior restricted stock unit grants dated 09/01/2022, 03/01/2023, 03/01/2024, and 03/01/2025.

Who is the selling party named in the Form 144 for RVMD?

The filing lists a selling contact at the address for Jack Anders c/o Revolution Medicines, Inc., 03/17/2026. The excerpt identifies the individual and address but does not provide additional attribution or beneficial‑ownership detail.

How many restricted stock units are listed and what are their grant dates?

The excerpt lists four restricted stock unit grants totaling individual awards of 318, 846, 840, and 649 shares with grant dates 09/01/2022, 03/01/2023, 03/01/2024, and 03/01/2025, respectively.

Does the Form 144 say how the sale proceeds will be used?

The provided excerpt does not state any use of proceeds or who receives the cash. The form records the sale amount $273,869.54 but includes no allocation or recipient information in the visible lines.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 06:15 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001800668
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Revolution Medicines, Inc.
SEC File Number	001-39219
Address of Issuer	700 SAGINAW DR REDWOOD CITY CALIFORNIA 94063
Phone	650-481-6801
Name of Person for Whose Account the Securities are To Be Sold	Anders Jack
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	ETRADE Financial Corporation 3 Edison Drive Alpharetta GA 30005	2653	408217.11	212596462	06/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/01/2022	Restricted stock unit grant	Issuer			318	09/01/2022	Services rendered
Common Stock	03/01/2023	Restricted stock unit grant	Issuer			846	03/01/2023	Services rendered
Common Stock	03/01/2024	Restricted stock unit grant	Issuer			840	03/01/2024	Services rendered
Common Stock	03/01/2025	Restricted stock unit grant	Issuer			649	03/01/2025	Services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jack Anders c/o Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	Common Stock	03/17/2026	2753	273869.54

144: Remarks and Signature

Remarks
Date of Notice	06/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/31/2023
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Jack Anders
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)